NCT01668810

Brief Summary

The investigators aimed to examine the psychotropic prescription pattern in China.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
7,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 20, 2012

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

August 20, 2012

Status Verified

July 1, 2012

Enrollment Period

2 months

First QC Date

August 16, 2012

Last Update Submit

August 17, 2012

Conditions

Prescription

Keywords

prescriptionschizophreniadepressionbipolar disorder

Study Arms (10)

Beijing region

include six hospitals

Guangdong Province

include 3 hospitals

Jiangsu province

include 3 hospitals

Hebei province

include 6 hospitals

Hubei Province

include 7 hospitals

Shanxi province

include 3 hospitals

Jiangxi province

include 3 hospitals

Jilin province

include 6 hospitals

Sichuan province

include 3 hospitals

Shaanxi province

include 3 hospitals

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

schizophrenia, depression and bipolar disorder patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of mental health, Peking University

Beijing, Beijing Municipality, 100191, China

RECRUITING

MeSH Terms

Conditions

SchizophreniaDepressionBipolar Disorder

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersBehavioral SymptomsBehaviorBipolar and Related DisordersMood Disorders

Study Officials

  • Xin Yu, MD.

    Peking University

    STUDY CHAIR

Central Study Contacts

Yun-Ai Su, Phd.

CONTACT

8610-82801960suyunai@gmail.com

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 16, 2012

First Posted

August 20, 2012

Study Start

July 1, 2012

Primary Completion

September 1, 2012

Study Completion

July 1, 2013

Last Updated

August 20, 2012

Record last verified: 2012-07

Locations

CN(1)